Taiwan FDA registration 4c34672ed4d3839e60e0c551d3733a95
“Dimension” Everolimus (EVRO) Assay
TW: “德曼遜” 癌伏妥試劑檢驗組
Taiwan·Risk Class 2·MD·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered May 04, 2022 – May 04, 2027ActiveRegistration details
- Analysis ID
- 4c34672ed4d3839e60e0c551d3733a95
- License Form
- Ministry of Health Medical Device Import No. 035243
- Customs Code
- DHA05603524309
Company information
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- This product needs to be used with the Dimension clinical chemistry system to quantitatively detect the content of Everolimus in human whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A3840 SIROLIMUS drug testing system
- Import Information
- Imported from abroad; GMP
Dates and status
- Registration Date
- May 04, 2022
- Expiry Date
- May 04, 2027
About this record
Access comprehensive regulatory information for “Dimension” Everolimus (EVRO) Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4c34672ed4d3839e60e0c551d3733a95 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices